Skip to content
DataLookout
Menu

DRAGONNCT07593404

Evaluation of a Novel Ocular Lubricating Eye Drop

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 9 words Show 5 more changesShow less
    • Primary completion moved earlier from Jan 2027 to Nov 2026
    • Study completion moved earlier from May 2027 to Feb 2027
    • Start date changed from estimate of May 2026 to May 28, 2026
    • Study description revised
    • Site details revised
  2. Notable Recruitment opened
    • Site details revised
    v2
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Number of Adverse Events
Timeframe: At the end of Part 1: 60 minutes after single drop monocular instillation and At the end of Part 2 (after 28 days of bilateral use)

Arms and interventions

Part 1Experimental

Part 1 Participants

Part 2Experimental

Part 2 Participants

Drugs: Part 2 ABR2 At least twice a day for 28 days, Part 1: ABR2 single dose in one eye

Sites

1 site in 1 country

  • Centre for Ocular Research & Education, School of Optometry & Vision Science, University of WaterlooWaterloo, Ontario, Canada